Skip Navigation



Human Molecular Genetics Advance Access published online on November 14, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm334
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
17/4/602    most recent
ddm334v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Weihofen, A.
Right arrow Articles by Selkoe, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weihofen, A.
Right arrow Articles by Selkoe, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1

Andreas Weihofen1, Beth Ostaszewski1, Yasufumi Minami2 and Dennis J. Selkoe1,*

1 Center for Neurologic Diseases Brigham and Women's Hospital and Harvard Medical School Boston, MA 02115 USA 2 Maebashi Institute of Technology Department of Biotechnology Gunma 371-0816 Japan

* To whom correspondence should be addressed: Center for Neurologic Diseases, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115 Tel: 617 525-5200; Fax: 617 525-5252; Email: dselkoe{at}rics.bwh.harvard.edu

Received June 25, 2007; Revised October 18, 2007; Accepted November 12, 2007

Mutations in the ubiquitously expressed gene Pink1 (PTEN-induced kinase 1) cause autosomal recessive Parkinson's disease (ARPD). Pink1 encodes a putative serine/threonine kinase with an N-terminal mitochondrial targeting sequence. The mechanism that leads to selective degeneration of dopaminergic neurons via Pink1 mutations is unknown. A full-length pre-protein (66 kD) and an N-terminally truncated mature form (55 kD) have been described in human brain. Here, we report that the endogenous 66 kD and 55 kD Pink1 forms in cultured cells are not exclusive to mitochondria but also occur in cytosolic and microsome-rich fractions. Pink1 66 kD is the predominant isoform in cultured cells. Using unbiased analyses of immunoisolated Pink1 complexes by mass spectrometry, co-immunoprecipitation and Hsp90 inhibitor studies, we identify Pink1 as a novel Cdc37/Hsp90 client kinase. This chaperone system influences both the subcellular distribution and the 66/55 kD protein ratio of Pink1. PD-causing Pink1 mutations decrease whereas Parkin expression increases the Pink1 66/55 kD protein ratio, biochemically linking Pink1 and Parkin and highlighting the potential relevance of this ratio for PD pathogenesis. Finally, we document the influence of Parkin on Pink1 subcellular distribution, providing further evidence for a common pathogenic pathway in recessive PD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E. A. Schon, and S. Przedborski
The kinase domain of mitochondrial PINK1 faces the cytoplasm
PNAS, August 19, 2008; 105(33): 12022 - 12027.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.